Альфа-пвп: описание и особенности

Alpha-PVP crystals often have sharp edges and varying sizes. The duration of high is approximately 3–5 hours for most routes of administration.

Alpha-PVP is considered a parent compound or closely related to MDPV in structural lineage within the cathinone class. Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.

Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours. The substance was marketed as 'legal highs' before being banned in many regions.

The chemical name alpha-pyrrolidinovalerophenone is synonymous with Alpha-PVP.

Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs. In animal studies, Alpha-PVP has been found to be equally potent and effective as MDPV in terms of reinforcing effects and locomotor stimulation.

The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing. Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations.

Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters. It is specifically illegal in New South Wales, Australia, following fatal incidents involving users.

It was placed under a temporary nationwide ban in the United States effective February 2014.

Primary causes of death linked to Alpha-PVP use include cardiac infarction and pulmonary edema. Psychosis and catatonia have been reported in severe cases of Alpha-PVP use.

Selective blockade of catecholamine transporters may increase addiction risk compared to non-selective substances. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures. Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data.

The European Union banned Alpha-PVP in 2015. Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Alpha-PVP was originally synthesized in the 1960s but did not enter widespread illicit use until the early 2000s.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'. Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control.

Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use.